share_log

Pfizer | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pfizer Inc. (“Pfizer” or the “Reporting Person”)(22.6%)

Pfizer | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Pfizer Inc. (“Pfizer” or the “Reporting Person”)(22.6%)

輝瑞 | SC 13D/A：超過5%持股股東披露文件(修正)-Pfizer Inc. (“Pfizer” or the “Reporting Person”)(22.6%)
美股sec公告 ·  07/29 16:36
Moomoo AI 已提取核心訊息
On July 29, 2024, Pfizer Inc. entered into a share purchase deed with Haleon PLC, providing a framework for off-market purchases of Haleon's ordinary shares by Pfizer. The agreement allows for purchases on multiple occasions, either in conjunction with future share offerings by Pfizer or as standalone transactions. The share purchase deed does not obligate either party to proceed with any purchase, and either Pfizer or Haleon may decline participation at their discretion. The terms of the deed will remain in effect until the approval of Haleon's shareholders expires and is not renewed at a subsequent annual general meeting. The transaction is subject to certain conditions, including shareholder approval, price range restrictions, and compliance with related party transaction rules...Show More
On July 29, 2024, Pfizer Inc. entered into a share purchase deed with Haleon PLC, providing a framework for off-market purchases of Haleon's ordinary shares by Pfizer. The agreement allows for purchases on multiple occasions, either in conjunction with future share offerings by Pfizer or as standalone transactions. The share purchase deed does not obligate either party to proceed with any purchase, and either Pfizer or Haleon may decline participation at their discretion. The terms of the deed will remain in effect until the approval of Haleon's shareholders expires and is not renewed at a subsequent annual general meeting. The transaction is subject to certain conditions, including shareholder approval, price range restrictions, and compliance with related party transaction rules under the Listing Rules. Pfizer, incorporated in Delaware, holds a significant number of Haleon's ordinary shares, and the agreement could potentially involve a considerable percentage of Haleon's issued share capital. The share purchase deed was executed as part of Amendment No. 8 to the Schedule 13D filed with the SEC, amending and supplementing previous disclosures.
輝瑞公司於2024年7月29日與Haleon PLC簽署了股份購買協議，爲輝瑞公司購買Haleon的普通股提供了框架。該協議允許分多次購買，可以作爲輝瑞未來股票發行的附屬交易，也可以單獨作爲交易。該份股份購買協議不需要雙方進行任何購買，並且輝瑞公司或Haleon可以自行決定是否參與。該協議的條款將一直有效，直到Haleon股東批准的有效期到期，並且在隨後的年度股東大會上未續訂。該交易受到特定條件的限制，包括股東批准、股價區間限制以及遵守上市規則下的相關方交易規則。輝瑞公司是在特拉華州註冊的，並持有Haleon普通股的大量份額，此協議可能涉及Haleon已發行股本的相當比例。該股份購買協議是作爲提交給美國證券交易委員會的13D表格修正案8的一部分執行的，修正和補充以前的披露。
輝瑞公司於2024年7月29日與Haleon PLC簽署了股份購買協議，爲輝瑞公司購買Haleon的普通股提供了框架。該協議允許分多次購買，可以作爲輝瑞未來股票發行的附屬交易，也可以單獨作爲交易。該份股份購買協議不需要雙方進行任何購買，並且輝瑞公司或Haleon可以自行決定是否參與。該協議的條款將一直有效，直到Haleon股東批准的有效期到期，並且在隨後的年度股東大會上未續訂。該交易受到特定條件的限制，包括股東批准、股價區間限制以及遵守上市規則下的相關方交易規則。輝瑞公司是在特拉華州註冊的，並持有Haleon普通股的大量份額，此協議可能涉及Haleon已發行股本的相當比例。該股份購買協議是作爲提交給美國證券交易委員會的13D表格修正案8的一部分執行的，修正和補充以前的披露。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息